Best Platelet Aggregation Inhibitor for Coronary Disease — ranked (2026) · pharmaranks
Best Platelet Aggregation Inhibitor for coronary disease
2 Platelet Aggregation Inhibitor drugs indicated for coronary disease, ranked by our independent rating. The current highest-rated is eptifibatide. Compare them with all treatments for coronary disease or the full Platelet Aggregation Inhibitor class. Not medical advice — always consult a professional.
Rated against independent regulatory sources·Last updated June 20, 2026·How we rate
Top platelet aggregation inhibitor for coronary disease:1. Eptifibatide · 2. Aggrastat
Best-rated Platelet Aggregation Inhibitor for coronary disease, ranked by pharmaranks score
What is the best platelet aggregation inhibitor for coronary disease?
By our independent rating, eptifibatide currently ranks highest among Platelet Aggregation Inhibitor drugs used for coronary disease. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
Which platelet aggregation inhibitor drugs treat coronary disease?
pharmaranks lists 2 Platelet Aggregation Inhibitor products indicated for coronary disease, per FDA drug-label data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.